VASOPRESSIN, POTASSIUM EXCRETION AND ACID-BASE BALANCE
VASOPRESSIN, POTASSIUM EXCRETION AND ACID-BASE BALANCE
批准号:
2144689
负责人:
DANIEL BATLLE
金额:
$14.64万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-02-01 至 1999-01-31
中文摘要
AVP是一种主要参与水运输的荷尔蒙。这一效果具有
已被证明是通过刺激肾脏中的受体来调节的
收集小管,即所谓的V2受体。拟议的研究旨在
确定精氨酸加压素(AVP)是否在血管紧张素转换酶中起生理学作用
人体内钾和酸碱的维持。具体来说,我们
想要验证这样的假设:(A)AVP增加了两个肾脏的钾
和通过刺激收集中的V2受体排酸
(B)膳食钾负荷和氯化铵负荷
刺激AVP的分泌,而饮食中缺钾有
相反的作用;和(C)缺钾会损害利尿剂
对AVP的反应,与它损害水渗透反应的方式大致相同
AVP,而膳食中的钾负荷会提高AVP。因此,更改
AVP的分泌及其对肾脏的放大/抑制作用是
被认为是钾和酸碱平衡的可能机制
可以在以下条件下保持:饮食中钾的摄入量和
酸是经过修饰的。
为了验证这一假说,我们将在健康的
肾功能正常的受试者。首先,我们将确定AVP是否
增加尿钾排泄和远端尿酸的探讨
这些影响的机制(S)。第二,钾的作用
负荷、缺钾和代谢性酸血症对AVP分泌的影响
将通过血浆AVP分泌对渗透压的反应来评估
刺激。第三,优先补钾和优先补钾的效果
缺钾对肾脏钾排泄和酸化的影响
将评估对生理剂量AVP输注的反应。
英文摘要
AVP is a hormone primarily involved in water transport. This effect has
been shown to be mediated by stimulation of receptors in the renal
collecting tubule, so called V2 receptors. The proposed study aims to
determine whether arginine vasopressin (AVP) plays a physiologic role in
maintaining potassium and acid-base in human subjects. Specifically, we
wish to test the hypothesis that (a) AVP increases both renal potassium
and acid excretion by stimulation of V2 receptors in the collecting
tubule; (b) dietary potassium loading and ammonium chloride loading
stimulate AVP secretion while dietary potassium deprivation has the
opposite effect; and (c) potassium deprivation will impair the kaliuretic
response to AVP, much the same way it impairs the hydroosmotic response to
AVP, while dietary potassium loading will enhance it. Thus, alterations
in AVP secretion and amplification/suppression of its renal actions are
postulated as possible mechanisms whereby potassium and acid-base balance
can be maintained under conditions where dietary intake of potassium and
acid are modified.
To test this hypothesis, we shall conduct a three-phase study in healthy
subjects with normal kidney function. First, we shall determine if AVP
increases potassium excretion and distal urinary acidification and explore
the mechanism (s) of these effects. Secondly, the effect of potassium
loading, potassium deprivation and metabolic acidemia on AVP secretion
will be assessed by the response of plasma AVP secretion to an osmotic
stimulus. Thirdly, the effect of prior potassium surplus and prior
potassium deprivation on the renal potassium excretory and acidification
responses to the infusion of physiologic amounts of AVP will be assessed.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Novel Short ACE2 variant for Delayed Graft Function
-
批准号:10514607
-
项目类别:
-
资助金额:$12.0万
-
财政年份:2021
-
负责人:DANIEL BATLLE
-
依托单位:
Novel Short ACE2 variant for Delayed Graft Function
-
批准号:10354793
-
项目类别:
-
资助金额:$32.0万
-
财政年份:2021
-
负责人:DANIEL BATLLE
-
依托单位:
Urinary Renin Angiotensin System in Diabetes
-
批准号:8964763
-
项目类别:
-
资助金额:$34.76万
-
财政年份:2015
-
负责人:DANIEL BATLLE
-
依托单位:
Urinary Renin Angiotensin System in Diabetes
-
批准号:9084563
-
项目类别:
-
资助金额:$34.76万
-
财政年份:2015
-
负责人:DANIEL BATLLE
-
依托单位:
Strategies for ACE2 Amplification to Treat Diabetic Kidney Disease
-
批准号:8139835
-
项目类别:
-
资助金额:$29.26万
-
财政年份:2009
-
负责人:DANIEL BATLLE
-
依托单位:
Strategies for ACE2 Amplification to Treat Diabetic Kidney Disease
-
批准号:8329016
-
项目类别:
-
资助金额:$29.26万
-
财政年份:2009
-
负责人:DANIEL BATLLE
-
依托单位:
Strategies for ACE2 Amplification to Treat Diabetic Kidney Disease
-
批准号:7735594
-
项目类别:
-
资助金额:$36.6万
-
财政年份:2009
-
负责人:DANIEL BATLLE
-
依托单位:
Strategies for ACE2 Amplification to Treat Diabetic Kidney Disease
-
批准号:7932763
-
项目类别:
-
资助金额:$32.61万
-
财政年份:2009
-
负责人:DANIEL BATLLE
-
依托单位:
Nocturnal Hypertension and Prevention of Microalbuminuria in Type I Diabetics
-
批准号:7289364
-
项目类别:
-
资助金额:$53.49万
-
财政年份:2006
-
负责人:DANIEL BATLLE
-
依托单位:
MECHANISMS OF NOCTURNAL HYPERTENSION IN TYPE 1 DIABETES
-
批准号:7604290
-
项目类别:
-
资助金额:$2.88万
-
财政年份:2006
-
负责人:DANIEL BATLLE
-
依托单位:
Nocturnal Hypertension and Prevention of Microalbuminuria in Type I Diabetics
-
批准号:7500086
-
项目类别:
-
资助金额:$53.95万
-
财政年份:2006
-
负责人:DANIEL BATLLE
-
依托单位:
Nocturnal Hypertension and Prevention of Microalbuminuria in Type I Diabetics
-
批准号:7100799
-
项目类别:
-
资助金额:$58.8万
-
财政年份:2006
-
负责人:DANIEL BATLLE
-
依托单位:
MECHANISMS OF NOCTURNAL HYPERTENSION IN TYPE 1 DIABETES
-
批准号:7376893
-
项目类别:
-
资助金额:$2.24万
-
财政年份:2005
-
负责人:DANIEL BATLLE
-
依托单位:
CELL GROWTH, NA/H EXCHANGE, AND CYCLINS IN IDDM PATIENTS
-
批准号:6138072
-
项目类别:
-
资助金额:$31.31万
-
财政年份:1999
-
负责人:DANIEL BATLLE
-
依托单位:
CELL GROWTH, NA/H EXCHANGE, AND CYCLINS IN IDDM PATIEN
-
批准号:6489704
-
项目类别:
-
资助金额:$32.81万
-
财政年份:1999
-
负责人:DANIEL BATLLE
-
依托单位:
CELL GROWTH, NA/H EXCHANGE, AND CYCLINS IN IDDM PATIENTS
-
批准号:6342513
-
项目类别:
-
资助金额:$32.05万
-
财政年份:1999
-
负责人:DANIEL BATLLE
-
依托单位:
CELL GROWTH, NA/H EXCHANGE, AND CYCLINS IN IDDM PATIENTS
-
批准号:2747875
-
项目类别:
-
资助金额:$31.84万
-
财政年份:1999
-
负责人:DANIEL BATLLE
-
依托单位:
ARGININE VASOPRESSIN (AVP), POTASSIUM EXCRETION AND ACID BASE BALANCE
-
批准号:6114069
-
项目类别:
-
资助金额:$2.05万
-
财政年份:1998
-
负责人:DANIEL BATLLE
-
依托单位:
ARGININE VASOPRESSIN (AVP), POTASSIUM EXCRETION AND ACID BASE BALANCE
-
批准号:6275304
-
项目类别:
-
资助金额:$2.26万
-
财政年份:1997
-
负责人:DANIEL BATLLE
-
依托单位:
VASOPRESSIN, POTASSIUM EXCRETION AND ACID-BASE BALANCE
-
批准号:2144687
-
项目类别:
-
资助金额:$13.8万
-
财政年份:1994
-
负责人:DANIEL BATLLE
-
依托单位:
海外基金